MedPath

Rapid on-site evaluation vs. randomly collected samples from mediastinal andabdominal lymph nodes obtained by endoscopic ultrasound-guided fine-needle-aspiratio

Recruiting
Conditions
lymphadenopathy
Registration Number
NL-OMON23056
Lead Sponsor
niversity Medical Center Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
234
Inclusion Criteria

≥18 years old

-EUS with FNA of a lymph node in either the mediastinum or abdomen

Exclusion Criteria

-Patients with a poor mental condition or mental retardation, unable to understand the nature and consequences of the study

-Coagulopathy (INR>1.5, platelets<50.000/mm3) which has not been corrected prior to the procedure

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the percentage of cases in which the local cytopathologist correctly diagnosed the lymph node, based on the EUS-FNA samples of the lymph node
Secondary Outcome Measures
NameTimeMethod
-Diagnostic yield (per case) of samples acquired with ROSE vs. without ROSE<br /><br>-Sensitivity, specificity, negative predictive value and positive predictive value of number of needle passes with ROSE vs. without ROSE<br /><br>-Result of evaluation of each sample by the cytotechnician on-site vs. that of the cytopathologist<br /><br>-Number of needle passes required according to the cytotechnician on-site vs. that of the cytopathologist<br /><br>-Procedural time of EUS-FNA with ROSE vs. without ROSE<br /><br>-Number and nature of complications of EUS-FNA with ROSE vs. without ROSE<br /><br>-Costs of EUS-FNA with ROSE vs. without ROSE
© Copyright 2025. All Rights Reserved by MedPath